XML 68 R33.htm IDEA: XBRL DOCUMENT v3.8.0.1
Organization and Significant Accounting Policies, Noncontrolling Interest in Akcea Therapeutics, Inc. (Details) - USD ($)
$ in Thousands
1 Months Ended 5 Months Ended 7 Months Ended 12 Months Ended
Jul. 31, 2017
Dec. 31, 2017
Jul. 18, 2017
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Akcea IPO [Abstract]            
Proceeds from sale of common stock to Novartis in a private placement       $ 50,000 $ 0 $ 0
Investment in subsidiary $ 25,000          
Percentage ownership before IPO     100.00%      
Percentage of results included in consolidation     100.00%      
Percentage ownership after IPO   68.00%        
Akcea [Member]            
Akcea IPO [Abstract]            
Gross proceeds from IPO 193,800          
Proceeds from sale of common stock to Novartis in a private placement 50,000          
Net proceeds from IPO $ 182,400